Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis
Not Applicable
Not yet recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- Other: Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 85
- Registration Number
- NCT05119452
Non-inferiority of Reduced-dose Rituximab in Rheumatoid Arthritis in Low Disease Activity and Remission
Phase 4
Terminated
- Conditions
- RemissionRheumatoid Arthritis
- Interventions
- Drug: 500mg RTX GroupDrug: 1000mg RTX Group
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 21
- Registration Number
- NCT05116228
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Diagnostic Test: PSMA PET ScanDiagnostic Test: FDHT PET Scan
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2023-03-17
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 10
- Registration Number
- NCT05109884
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Mold Allergy in Austria: Clinical Relevance of Alternaria Alternata and Related Species
- Conditions
- Fungal AllergyAllergy
- Interventions
- Diagnostic Test: Nasal provocationDiagnostic Test: Collection of nasal secretionDiagnostic Test: Skin-Prick TestDiagnostic Test: Blood draw
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 70
- Registration Number
- NCT05101733
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
Phase 4
Recruiting
- Conditions
- Exudative Macular Degeneration
- Interventions
- Drug: anti-VEGF agent
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 290
- Registration Number
- NCT05093374
- Locations
- 🇦🇹
Department of Ophthalmology, Medical University of Vienna, Austria, Vienna, Austria
Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021
Completed
- Conditions
- Covid 19Influenza
- Interventions
- Diagnostic Test: PCR or antigen test for Covid 19 or Inluenza
- First Posted Date
- 2021-10-21
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 440000
- Registration Number
- NCT05087355
Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Phase 3
- Conditions
- Atrial FibrillationPostoperative Complications
- Interventions
- Drug: Landiolol HClDrug: Placebo
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 164
- Registration Number
- NCT05084118
- Locations
- 🇦🇹
University Hospital Vienna, Vienna, Austria
Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation
Recruiting
- Conditions
- Hip Fractures
- Interventions
- Procedure: Early Surgical Fixation vs. Delayed Surgical Fixation
- First Posted Date
- 2021-10-07
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 140
- Registration Number
- NCT05070169
- Locations
- 🇦🇹
Medical University of Vienna, Department of Traumatology, Vienna, Austria
Left Renal Vein Division for Juxtarenal Aortic Exposure
- Conditions
- Aortic AneurysmJuxtarenal Aortic AneurysmRenal Function Disorder
- Interventions
- Procedure: Exclusion of the aortic aneurysm.
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 110
- Registration Number
- NCT05054972
- Locations
- 🇦🇹
Department of Vascular Surgery, Medical University of Vienna, Vienna, Austria
Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact
Not Applicable
Recruiting
- Conditions
- Allergy
- Interventions
- Procedure: Blood samplingProcedure: Nasal biopsiesBiological: Nasal specimen collectionProcedure: Mucosal RNA samplingProcedure: Intranasal challengeProcedure: Skin prick testProcedure: Peak Nasal Inspiratory Flow (PNIF)Biological: Pregnancy test
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT05042830
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath